Development and Validation of a Pre-Transplant Risk Score (LT-MVI Score) to Predict Microvascular Invasion in Hepatocellular Carcinoma Candidates for Liver Transplantation
<b>Background/Objectives:</b> MVI is a relevant prognostic factor among patients with hepatocellular carcinoma (HCC) receiving liver transplantation (LT). The preoperative assessment of the risk for MVI is relevant to pre-LT patient management and selection. The objective of this study was to create and validate a model to predict microvascular invasion (MVI) based on preoperative variables in the LT setting. <b>Methods</b>: A total of 2170 patients from 11 collaborative centers in Europe, Asia, and the US, who received transplants between 1 January 2000 and 31 December 2017, were enrolled in the study. The entire cohort was split into a training and a validation set (70/30% of the initial cohort, respectively) using random selection. <b>Results</b>: MVI was reported in 586 (27.0%) explanted specimens. Using the training set data, multivariable logistic regression identified three preoperative parameters associated with MVI: α-fetoprotein (lnAFP; odds ratio [OR] = 1.19; 95% confidence interval [CI] = 1.13-1.27), imaging tumor burden score (lnTBS; OR = 1.66; 95%CI = 1.39-1.99), and a fast-track approach before LT due to the availability of a live donation (OR = 1.99; 95%CI = 1.56-2.53). In the validation set, the LT-MVI c-index was 0.74, versus 0.69 for the MVI score proposed by Endo et al. (Brier Skill Score +75%). The new score had a relevant net reclassification index (overall value = 0.61). Stratifying the validation set into three risk categories (0-50th, 51st-75th, and >75th score percentiles), a very good stratification was observed in terms of disease-free (5-year: 89.3, 75.5, and 50.7%, respectively) and overall survival (5-year: 79.5, 72.6, and 53.7%, respectively). <b>Conclusions</b>: The preoperative assessment of MVI using the proposed score demonstrated very good accuracy in predicting MVI after LT.
Authors
- Albert Chan (ORCID: https://orcid.org/0000-0002-1383-2952)
- Maria Hoppe‐Lotichius (ORCID: https://orcid.org/0000-0003-2080-7832)
- Prashant Bhangui (ORCID: https://orcid.org/0000-0002-4839-5852)
- Marlene Panzer (ORCID: https://orcid.org/0000-0003-1957-412X)
- Umberto Cillo (ORCID: https://orcid.org/0000-0002-2310-0245)
- Jens Mittler (ORCID: https://orcid.org/0000-0002-2469-6036)
- Karim J. Halazun (ORCID: https://orcid.org/0000-0002-8971-3626)
- Tomoharu Yoshizumi (ORCID: https://orcid.org/0000-0002-4497-1816)
- Tiffany Wong (ORCID: https://orcid.org/0000-0002-3142-7678)
- Etsuro Hatano (ORCID: https://orcid.org/0000-0003-3407-1918)
- Timothy Michael Pawlik (ORCID: https://orcid.org/0000-0002-7994-9870)
- Massimo Rossi (ORCID: https://orcid.org/0000-0001-5105-4656)
- Jean Emond
- Takeo Toshima (ORCID: https://orcid.org/0000-0003-4019-8288)
- Takashi Ito (ORCID: https://orcid.org/0000-0002-4148-4086)
- Laurent Coubeau (ORCID: https://orcid.org/0000-0002-3968-5591)
- Alessandro Vitale (ORCID: https://orcid.org/0000-0002-4548-8308)
- Quirino Lai (ORCID: https://orcid.org/0000-0003-1487-3235)
- Jan Lerut (ORCID: https://orcid.org/0000-0003-4015-463X)
- Benedikt Schaefer (ORCID: https://orcid.org/0000-0001-8690-2774)
- Suela Ajdini
- Arvinder S. Soin
- Chih-Che Lin
- Chao‐Long Chen
Institutions
- Medanta The Medicity (IN)
- NewYork–Presbyterian Hospital (US)
- Kyushu University (JP)
- University of Padua (IT)
- Innsbruck Medical University (AT)
- Chang Gung University (TW)
- Universität Innsbruck (AT)
- Johannes Gutenberg University Mainz (DE)
- Kyoto University (JP)
- Policlinico Umberto I (IT)
- Queen Mary Hospital (CN)
- New York Hospital Queens (US)
- The Ohio State University Wexner Medical Center (US)
- NYU Langone Health (US)
- Kaohsiung Chang Gung Memorial Hospital (TW)
- Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie (DE)
- Columbia University (US)
- Sapienza University of Rome (IT)
- University of Hong Kong (HK)
- UCLouvain (BE)
Publication Details
- Journal
- Cancers
- Published
- 2025-04-24
- DOI
- https://doi.org/10.3390/cancers17091418
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32